ARNUITY Ellipta® 100 mcg is a prescription inhalation powder containing fluticasone furoate, a potent corticosteroid used for the long-term maintenance treatment of asthma in adults and children aged 5 years and older. This once-daily inhaler reduces airway inflammation, helping to prevent asthma symptoms such as wheezing, coughing, and shortness of breath. ARNUITY Ellipta® works to control asthma and improve lung function when used regularly as part of a comprehensive asthma management plan.

Features:

• Effective Corticosteroid Therapy: ARNUITY Ellipta® 100 mcg contains fluticasone furoate, a powerful anti-inflammatory agent that targets and reduces inflammation in the airways, helping to prevent asthma symptoms and reduce flare-ups.

• FDA-Approved: ARNUITY Ellipta® is FDA-approved for the long-term maintenance treatment of asthma in patients 5 years and older. It is not intended for the relief of acute asthma attacks or sudden breathing problems.

• Once-Daily Dosing: ARNUITY Ellipta® is designed for once-daily use, with just one inhalation per day. It provides 24-hour relief from asthma symptoms, improving overall lung function and reducing the risk of asthma exacerbations.

• Convenient Inhaler Design: The Ellipta® inhaler is easy to use, featuring a simple, pre-dosed system. No preparation or shaking is required, making it convenient for patients to take their medication every day.